Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections follow a once-weekly dosing schedule, with doses that typically begin at 0.25 mg and escalate in increments over several months to reach an effective maintenance level. Understanding this injection frequency and escalation pattern helps patients plan their treatment timeline and manage expectations for weight loss results. PlexusDx provides compounded semaglutide injections from licensed 503A pharmacies, allowing you to start treatment without insurance requirements.

Start your GLP-1 program with PlexusDx

One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.

Start your intake →

Understanding Weekly Semaglutide Injection Frequency

Semaglutide injections are administered once per week, typically on the same day each week to maintain consistent blood levels of the medication. This once-weekly dosing schedule makes treatment manageable for patients who prefer predictable injection routines. Unlike insulin or other frequent-injection therapies, the long half-life of semaglutide allows it to remain effective in your system for approximately seven days after each injection.

The weekly injection timing can be adjusted slightly based on your personal schedule—for example, you might inject every Monday morning or every Thursday evening. Consistency matters more than the exact time of day, as long as you maintain roughly seven-day intervals between doses. Many patients find it helpful to set phone reminders during their first few months of treatment until the weekly routine becomes automatic.

Standard Semaglutide Dosing Escalation Protocol

Most semaglutide treatment plans follow a four-step dose escalation over 16 weeks: starting at 0.25 mg in week one, advancing to 0.5 mg by week five, reaching 1.0 mg by week nine, and potentially continuing to 1.7 or 2.4 mg depending on individual response and tolerance. This gradual increase reduces gastrointestinal side effects and allows your body to adjust to the medication's appetite-suppressing effects. Each dose increase occurs at four-week intervals, giving you time to assess how your body responds before moving to the next level.

Some patients reach their effective dose earlier than others, while some benefit from higher maintenance doses to achieve their weight loss goals. Your PlexusDx provider can adjust your escalation timeline based on how you tolerate each dose level and how your appetite and eating patterns respond. The key principle is finding your personal therapeutic dose—the amount that delivers maximum weight loss benefit with side effects you can manage.

How PlexusDx Personalizes Your Injection Schedule

PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month) to analyze how your body responds to GLP-1 receptor activation and related metabolic pathways. This test examines key genetic variants including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313—markers that influence how effectively your body processes semaglutide and related peptides. By mapping 14 pathways across 150+ genetic insights, PlexusDx helps identify whether you may benefit from standard escalation, faster advancement, or continued microdose therapy.

Your compounded semaglutide injection from PlexusDx is $189/mo month-to-month (or $149/mo on the 6-month plan) flat—your dose may need to go up, but your price won't. This transparent pricing model removes the uncertainty of cost increases as your provider adjusts your dosing level. PlexusDx's licensed 503A compounding pharmacies prepare your medication to match your personalized protocol, whether you escalate quickly or require a slower titration approach.

Factors That May Change Your Injection Schedule

Side effects like nausea, vomiting, or constipation may prompt your provider to pause your dose escalation or reduce back to a previous level, extending your overall treatment timeline. Conversely, excellent tolerance and steady weight loss may support advancing to higher doses on schedule or even jumping to maintenance doses faster than the standard protocol. Individual health factors—including kidney function, prior medication responses, and metabolic conditions—influence how quickly or slowly your provider advances your semaglutide dosing.

Life events such as illness, surgery, or significant stress may temporarily interrupt your weekly injection schedule or delay dose increases while your body stabilizes. Pregnancy planning, active infections, or acute medical conditions require discussion with your provider about pausing or modifying your semaglutide regimen. PlexusDx providers assess these clinical factors during regular check-ins to ensure your injection schedule remains safe and effective for your unique situation.

Missed or Delayed Semaglutide Injections: What to Know

If you miss your weekly semaglutide injection by one or two days, you can still take your scheduled dose when you remember—no dose doubling is necessary. However, if you miss a full week or more, contact your PlexusDx provider to discuss whether you should resume your current dose, drop back to a lower dose, or schedule a follow-up visit before restarting. Gaps in treatment allow the medication to clear from your system, which may reset your tolerance and require adjusted dosing when you resume.

The once-weekly injection schedule means you're unlikely to experience dangerous fluctuations from minor delays, unlike daily medications. Most patients who miss an injection find that resuming the following week without special adjustments works well. For patients who travel frequently or have irregular schedules, working with your PlexusDx provider to establish a flexible but consistent injection day (like every Monday regardless of which week) reduces the risk of missed doses.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How many times per week do I inject semaglutide?

Semaglutide is injected once per week, always on the same day of the week for consistency. You'll maintain this weekly schedule throughout your treatment, with your dose amount changing during the first 16-20 weeks as you escalate, then remaining steady at your maintenance dose.

What is the typical timeline for increasing my semaglutide dose?

Standard escalation increases your dose every four weeks over 16 weeks: 0.25 mg (week 1), 0.5 mg (week 5), 1.0 mg (week 9), and potentially 1.7 or 2.4 mg thereafter. Your PlexusDx provider may adjust this timeline based on your tolerance and response, or suggest the Precision Peptide Genetic Test to identify your optimal dosing pattern.

Does my price increase as my semaglutide dose goes up?

No. PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan flat—your dose may need to go up, but your price won't. You pay the same monthly rate regardless of which dose level you're taking, with no hidden per-dose charges or tier upgrades.

What are common side effects during the semaglutide escalation phase?

Nausea, vomiting, constipation, and loss of appetite are common during dose increases, typically improving within a few days as your body adjusts. If side effects are severe or persistent, your provider may pause escalation, reduce your dose, or recommend dietary strategies. Most side effects resolve by week two to three at each dose level.

Can genetic testing help optimize my semaglutide injection schedule?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves